Brain imaging offers a way to examine how different regions of the brain participate in cognitive function”— Dr.

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Diagnosing inflammation in large blood vessels can be difficult, especially when standard tests appear normal. In this study, researchers tested a new PET imaging tracer that targets an ...

The US Food and Drug Administration (FDA) today announced approved of flutemetamol F18 injection (Vizamyl, GE Healthcare), a radioactive diagnostic tracer for use with positron emission tomography ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. The ...

Findings support clinical application of molecular imaging and use of novel immune cell targeting tracers for development of ...

This article explores how advanced immune imaging technologies enable real-time visualization of immune responses, improving ...